
The contracts mark Injectiveβs first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.

The contracts mark Injectiveβs first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.
Connectingβ¦